Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd R Burmester

Showing results (251-260 of 293) with videos related to

Pageof 30
Sort By:
Annals of the Rheumatic Diseases|June 7, 2020
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2Robert Bm Landewé, Pedro M Machado, Féline Kroon, et al.
Journal of Clinical Medicine|July 14, 2023
Intestinal Microbiota Reduction Followed by Fasting Discloses Microbial Triggering of Inflammation in Rheumatoid ArthritisThomas Häupl, Till Sörensen, Biljana Smiljanovic, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partnersLuca Iaccarino, Rosaria Talarico, Emanuele Bozzalla-Cassione, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2014
Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosisMike O Becker, Angela Kill, Marissa Kutsche, et al.
Annals of the Rheumatic Diseases|January 16, 2021
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trialRené Westhovens, William F C Rigby, Désirée van der Heijde, et al.
Arthritis Research & Therapy|March 8, 2008
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyAntonio Naranjo, Tuulikki Sokka, Miguel A Descalzo, et al.
Annals of the Rheumatic Diseases|February 4, 2019
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, et al.
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|August 9, 2011
Delays in assessment of patients with rheumatoid arthritis: variations across EuropeKarim Raza, Rebecca Stack, Kanta Kumar, et al.
Annals of the Rheumatic Diseases|February 5, 2013
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteriaDésirée van der Heijde, Annette H M van der Helm-van Mil, Daniel Aletaha, et al.
Pageof 30

Showing results (251-260 of 293) with videos related to

Sort By:
Pageof 30
Annals of the Rheumatic Diseases|June 7, 2020
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2Robert Bm Landewé, Pedro M Machado, Féline Kroon, et al.
Journal of Clinical Medicine|July 14, 2023
Intestinal Microbiota Reduction Followed by Fasting Discloses Microbial Triggering of Inflammation in Rheumatoid ArthritisThomas Häupl, Till Sörensen, Biljana Smiljanovic, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partnersLuca Iaccarino, Rosaria Talarico, Emanuele Bozzalla-Cassione, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2014
Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosisMike O Becker, Angela Kill, Marissa Kutsche, et al.
Annals of the Rheumatic Diseases|January 16, 2021
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trialRené Westhovens, William F C Rigby, Désirée van der Heijde, et al.
Arthritis Research & Therapy|March 8, 2008
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyAntonio Naranjo, Tuulikki Sokka, Miguel A Descalzo, et al.
Annals of the Rheumatic Diseases|February 4, 2019
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, et al.
The Journal of Rheumatology|April 3, 2008
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|August 9, 2011
Delays in assessment of patients with rheumatoid arthritis: variations across EuropeKarim Raza, Rebecca Stack, Kanta Kumar, et al.
Annals of the Rheumatic Diseases|February 5, 2013
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteriaDésirée van der Heijde, Annette H M van der Helm-van Mil, Daniel Aletaha, et al.
Pageof 30